Recent advances of chimeric antigen receptor T‐cell therapy for acute myeloid leukemia
Acute myeloid leukemia (AML) is a heterogeneously primary hematopoietic neoplasm characterized by uncontrolled proliferation of immature myeloid cells, which is characterized with poor outcomes. Despite tremendous advances in the treatment paradigm of AML in the past several decades, the cure and pr...
Saved in:
| Main Authors: | Yang Liu, Wanting Wang, Chaofan Wang, Jun Deng, Yu Hu, Heng Mei, Shanshan Luo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1572407/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adoptitive immunotherapy with genetically engineered T lymphocytes modified to express chimeric antigen receptors
by: A. А. Pavlova, et al.
Published: (2017-04-01) -
CAR-macrophages targets CD26 to eliminate chronic myeloid leukemia stem cells
by: Jiang Guoyun, et al.
Published: (2025-02-01) -
The use of T-cells with chimeric antigen receptor (CAR-T) in combination with chemotherapy and radiotherapy for the treatment of solid tumors
by: M. R. Khaliulin, et al.
Published: (2024-04-01) -
Revolutionizing Allogeneic Graft Tolerance Through Chimeric Antigen Receptor-T Regulatory Cells
by: Alvin Man Lung Chan, et al.
Published: (2025-07-01) -
Function and mechanism of cancer-testis antigen CT63 in chronic myeloid leukemia
by: KONG Ruxin, et al.
Published: (2024-11-01)